OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022 at 06:50 pm EDT
Share
OK Biotech Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 435.89 million compared to TWD 300.51 million a year ago. Net income was TWD 53.77 million compared to net loss of TWD 0.166 million a year ago. Basic earnings per share from continuing operations was TWD 0.57. Diluted earnings per share from continuing operations was TWD 0.52. Basic earnings per share was TWD 0.57. Diluted earnings per share was TWD 0.52.
For the six months, sales was TWD 853.02 million compared to TWD 596.46 million a year ago. Net income was TWD 102.47 million compared to TWD 29.6 million a year ago. Basic earnings per share from continuing operations was TWD 1.09 compared to TWD 0.31 a year ago. Diluted earnings per share from continuing operations was TWD 0.96 compared to TWD 0.27 a year ago. Basic earnings per share was TWD 1.09 compared to TWD 0.31 a year ago. Diluted earnings per share was TWD 0.96 compared to TWD 0.27 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.